dc.contributor.author
Rodriguez Valero, Natalia
dc.contributor.author
Castro, P.
dc.contributor.author
Martinez, G.
dc.contributor.author
Marco Hernández, Javier
dc.contributor.author
Fernandez, S.
dc.contributor.author
Gascón i Brustenga, Joaquim
dc.contributor.author
Nicolás Arfelis, Josep Maria
dc.date.issued
2018-09-10T11:52:08Z
dc.date.issued
2018-12-27T06:10:25Z
dc.date.issued
2017-12-27
dc.date.issued
2018-09-10T11:52:08Z
dc.identifier
https://hdl.handle.net/2445/124442
dc.description.abstract
Blackwater fever was typically reported after quinine administration, although it is poor recognized in patients receiving artesunate. This case describes a blackwater fever in a non-immune patient after artesunate for severe malaria. It highlights the importance of monitoring haemolytic parameters in severe malaria to avoid renal impairment or severe anaemia.
dc.format
application/pdf
dc.publisher
Oxford University Press
dc.relation
Versió postprint del document publicat a: https://doi.org/10.1093/jtm/tax094
dc.relation
Journal of Travel Medicine, 2018, vol. 25, num. 1, p. tax094
dc.relation
https://doi.org/10.1093/jtm/tax094
dc.rights
(c) International Society of Travel Medicine, 2018
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Medicina)
dc.subject
Plasmodium falciparum
dc.subject
Plasmodium falciparum
dc.title
Blackwater fever in a non-immune patient with Plasmodium falciparum malaria after intravenous artesunate
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/acceptedVersion
